Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,236 across all filing types
Latest filing 2022-11-14 Director's Dealing
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
111年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of insiders, including directors, general managers, and their related parties. It shows the number of shares held, increases, decreases, and other shareholding details. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is not a report publication announcement or a certification. Given the detailed insider shareholding data, this fits the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives.
2022-11-14 Chinese
111年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of insiders, including directors, supervisors, and senior management, with specific numbers of shares held, pledged shares, and related percentages. It is focused on insider shareholdings and changes thereof. There is no indication of financial results, earnings, management discussion, or other report types. The document is a notification of insider shareholdings and their changes, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions by company directors and executives. The document length is about 5607 characters, which is sufficient for a detailed insider shareholding report. Therefore, the classification is DIRS with high confidence.
2022-11-14 Chinese
111年第3季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a financial disclosure related to investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for the current period. It is relatively short (772 characters) and appears to be a regulatory disclosure of investment details rather than a full financial report. There is no indication that this is an annual or interim report, audit report, or earnings release. It does not contain management discussion or call transcript content. The document is a specific regulatory filing of investment information, likely submitted to a public information observatory. Given the short length and nature, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2022-11-10 Chinese
111年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning the company's investments in mainland China. It includes specific financial figures, investment methods, and regulatory approval limits. The content is regulatory in nature, providing compliance information about overseas investments, but it does not constitute a full financial report, earnings release, or management discussion. The document length is short (1486 characters), and it is a regulatory disclosure likely filed to comply with investment reporting requirements. There is no indication that this is an announcement of a report publication or a certification. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2022-11-10 Chinese
111年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 神隆, providing information about loan balances and endorsement guarantees for the current and previous months. It contains tabulated data on financial guarantees and limits but does not include comprehensive financial statements or detailed analysis. The document length is short (626 characters), and it appears to be a regulatory disclosure of financial status rather than a full report or announcement of a report. There is no indication of an annual or interim report, audit report, or other detailed filings. This type of document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2022-11-09 Chinese
111年10月營業收入
Regulatory Filings Classification · 90% confidence The document is a revenue summary report for a company named 神隆, showing monthly and cumulative net operating revenue figures for a specific month (October of 民國111年, which corresponds to 2022). It includes comparative figures from the previous year and percentage changes. The document is short (772 characters) and appears to be a periodic financial summary rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It also does not fit other categories like Earnings Release or Investor Presentation. Given the nature of the data and the format, this is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2022-11-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.